Stratipath CMO Johan Hartman participated in an enlightening seminar at Techarenan during Almedalsveckan in Visby: Seminar – Almedalen. ”AI can predict relapse in breast cancer – How does this affect breast cancer care?”. Together with partners from the SwAIPP (Swedish AI Precision Pathology) innovation consortium, we discussed the transformative impact of AI solutions in breast cancer diagnostics.
Other panelists:
Susanne Dieroff Hay, President, Bröstcancerförbundet (Swedish breast cancer association)
Tobias Lundin Gerdås, Head of Public Relations, Roche Diagnostics Sweden
Moderator: Karin Ekberg, Head of Advocacy, Bröstcancerförbundet
Missed the seminar? Don’t worry! The full talk is now available to stream. Dive into how AI can revolutionize breast cancer care, offering faster, more precise, and cost-effective diagnostics. Watch the video here:
